WaferGen Bio Revenue vs. Working Capital
Considering WaferGen Bio's profitability and operating efficiency indicators, WaferGen Bio systems may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in May. Profitability indicators assess WaferGen Bio's ability to earn profits and add value for shareholders.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Please note, there is a significant difference between WaferGen Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if WaferGen Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, WaferGen Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
For WaferGen Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of WaferGen Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well WaferGen Bio systems utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between WaferGen Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of WaferGen Bio systems over time as well as its relative position and ranking within its peers.
WaferGen |
WaferGen Bio systems Working Capital vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining WaferGen Bio's current stock value. Our valuation model uses many indicators to compare WaferGen Bio value to that of its competitors to determine the firm's financial worth. WaferGen Bio systems is rated below average in revenue category among related companies. It is rated fifth in working capital category among related companies reporting about 0.42 of Working Capital per Revenue. The ratio of Revenue to Working Capital for WaferGen Bio systems is roughly 2.37 . Comparative valuation analysis is a catch-all model that can be used if you cannot value WaferGen Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for WaferGen Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the WaferGen Bio's earnings, one of the primary drivers of an investment's value.WaferGen Working Capital vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
WaferGen Bio |
| = | 9.24 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
WaferGen Bio |
| = | 3.9 M |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
WaferGen Working Capital Comparison
WaferGen Bio is currently under evaluation in working capital category among related companies.
WaferGen Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in WaferGen Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, WaferGen Bio will eventually generate negative long term returns. The profitability progress is the general direction of WaferGen Bio's change in net profit over the period of time. It can combine multiple indicators of WaferGen Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
WaferGen Biosystems, Inc. develops, manufactures, and sells systems for singlecell analysis and clinical research in the United States, Canada, Europe, and the Asia Pacific.
WaferGen Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on WaferGen Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of WaferGen Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the WaferGen Bio's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in WaferGen Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Use Investing Themes to Complement your WaferGen Bio position
In addition to having WaferGen Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Chemicals Thematic Idea Now
Chemicals
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Chemicals theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Chemicals Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the WaferGen Bio systems information on this page should be used as a complementary analysis to other WaferGen Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in WaferGen Stock
If you are still planning to invest in WaferGen Bio systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the WaferGen Bio's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |